Send to a Friend Font Size: Increase Decrease

MSCLF and MSLE Related Headlines

Feb 12, 2026 07:00AM Satellos begins phase 2 trial of SAT-3247 for duchenne muscular dystrophy
Feb 12, 2026 07:00AM Satellos Announces First Participant Dosed in Phase 2 Pediatric Study of SAT-3247 for Duchenne Muscular Dystrophy

MSCLF and MSLE Related Press Releases

Feb 12, 2026 07:00AM Satellos Announces First Participant Dosed in Phase 2 Pediatric Study of SAT-3247 for Duchenne Muscular Dystrophy

MSCLF and MSLE Related SEC Filings

Feb 24, 2026 07:15AM Form 6-K Satellos Bioscience Inc. For: Feb 24
Feb 19, 2026 11:05AM Form 6-K Satellos Bioscience Inc. For: Feb 19
Feb 18, 2026 02:03PM Form 6-K Satellos Bioscience Inc. For: Feb 18
Feb 17, 2026 03:23PM Form 6-K Satellos Bioscience Inc. For: Feb 17
Feb 12, 2026 07:15AM Form 6-K Satellos Bioscience Inc. For: Feb 10
Feb 10, 2026 07:15AM Form 6-K Satellos Bioscience Inc. For: Feb 10
Feb 10, 2026 06:03AM Form 6-K Satellos Bioscience Inc. For: Feb 09